TP53 and chronic kidney disease: We tested this hypothesis by evaluating the effects of JT on SIRT3 and acetylated P53 levels in a mouse CKD model and assessed the related changes in the expression of GPX4/solute carrier family 7 member 11 (SLC7A11) in the tissues of SIRT3−/− mice.